Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Agnuside

Catalog No. T3868Cas No. 11027-63-7
Alias chasteberry oil

Agnuside (chasteberry oil) inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3, 66.8, and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5, 25, and 100 μM, respectively.

Agnuside

Agnuside

Purity: 99.81%
Catalog No. T3868Alias chasteberry oilCas No. 11027-63-7
Agnuside (chasteberry oil) inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3, 66.8, and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5, 25, and 100 μM, respectively.
Pack SizePriceAvailabilityQuantity
1 mg$39In Stock
5 mg$98In Stock
10 mg$148In Stock
25 mg$249In Stock
50 mg$369In Stock
100 mg$548In Stock
1 mL x 10 mM (in DMSO)$110In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Agnuside"

Select Batch
Purity:99.81%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Agnuside (chasteberry oil) inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3, 66.8, and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5, 25, and 100 μM, respectively.
Targets&IC50
COX-2:0.026 mg/mL
In vitro
Agnuside (0.1-10 μM) induces proliferation of MCF-7 breast cancer cells, an effect that is inhibited by the estrogen receptor antagonist fulvestrant [2].
In vivo
Agnuside (50 mg/kg) reduces acetic acid-induced writhing in mice indicating analgesia.3 It also suppresses production of the pro-inflammatory mediators' prostaglandin E2 (PGE2) and leukotriene B4 and the T cell-mediated cytokines IL-2, TNF-α, INF-γ, IL-4, IL-10, and IL-17 in splenocytes and arthritic paw tissue from arthritic adrenalectomized rats.4
Aliaschasteberry oil
Chemical Properties
Molecular Weight466.44
FormulaC22H26O11
Cas No.11027-63-7
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 50 mg/mL (107.19 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1439 mL10.7195 mL21.4390 mL107.1949 mL
5 mM0.4288 mL2.1439 mL4.2878 mL21.4390 mL
10 mM0.2144 mL1.0719 mL2.1439 mL10.7195 mL
20 mM0.1072 mL0.5360 mL1.0719 mL5.3597 mL
50 mM0.0429 mL0.2144 mL0.4288 mL2.1439 mL
100 mM0.0214 mL0.1072 mL0.2144 mL1.0719 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Agnuside | purchase Agnuside | Agnuside cost | order Agnuside | Agnuside chemical structure | Agnuside in vivo | Agnuside in vitro | Agnuside formula | Agnuside molecular weight